Dr. Schwartzbard's main areas of focus include atherosclerosis and lipids. He recently received an AHA research grant to study the effects of a TZD in patients with insulin resistance. He is currently also participating in a VA funded study in transthyretin amyloidosis and echocardiography. Together with Dr. Ed Fisher and colleagues at the NYU Lipid center, he is involved in several funded studies on lipids, angiotensin blockade, hypertension and atherosclerosis.